These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 16359751

  • 1. Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer.
    Celikoglu F, Celikoglu SI, York AM, Goldberg EP.
    Lung Cancer; 2006 Feb; 51(2):225-36. PubMed ID: 16359751
    [Abstract] [Full Text] [Related]

  • 2. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
    Yuan S, Sun X, Li M, Yu J, Ren R, Yu Y, Li J, Liu X, Wang R, Li B, Kong L, Yin Y.
    Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299
    [Abstract] [Full Text] [Related]

  • 3. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer.
    Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A.
    N Engl J Med; 1992 Feb 20; 326(8):524-30. PubMed ID: 1310160
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment in advanced stages (IIIb-IV) of non-small cell lung cancer.
    Mariotta S, Sposato B, Li Bianchi E, Fiorucci F, Ricci A, Carbone F, Crescenzi M, Schmid G.
    Eur Rev Med Pharmacol Sci; 2002 Feb 20; 6(2-3):49-54. PubMed ID: 12708610
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 20; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 6. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
    Spásová I, Petera J.
    Neoplasma; 2001 Sep 20; 48(3):234-40. PubMed ID: 11583295
    [Abstract] [Full Text] [Related]

  • 7. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.
    Chen YM, Perng RP, Shih JF, Whang-Peng J.
    Lung Cancer; 2008 Aug 20; 61(2):214-9. PubMed ID: 18243407
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of curative and palliative radiotherapy efficacy in extensive stage small cell lung cancer.
    Diniz G, Unlu I, Gokce T, Kilciksiz S, Gayaf M, Komurcuoglu B, Karadogan I, Aktas S, Akcay C.
    Saudi Med J; 2006 Jul 20; 27(7):992-6. PubMed ID: 16830017
    [Abstract] [Full Text] [Related]

  • 9. [Combined radiotherapy and chemotherapy modalities in the treatment of lung cancer].
    Furuse K, Kawahara M, Arai R, Kodama N, Yamamoto M, Kubota K, Ogawara M, Nakai R.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 2-3):1628-33. PubMed ID: 2837998
    [Abstract] [Full Text] [Related]

  • 10. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 20; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 13. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug 10; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 14. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
    Daly BD, Fernando HC, Ketchedjian A, Dipetrillo TA, Kachnic LA, Morelli DM, Shemin RJ.
    Ann Thorac Surg; 2006 Jul 10; 82(1):227-31. PubMed ID: 16798219
    [Abstract] [Full Text] [Related]

  • 15. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H, Hilger R.
    Support Care Cancer; 2003 Jan 10; 11(1):1-10. PubMed ID: 12527948
    [Abstract] [Full Text] [Related]

  • 16. Combination of interventional pulmonology techniques (Nd:YAG laser resection and brachytherapy) with external beam radiotherapy in the treatment of lung cancer patients with Karnofsky Index < or =50.
    Canak V, Zarić B, Milovancev A, Jovanović S, Budisin E, Sarcev T, Lalić N, Nisević V, Balaban G.
    J BUON; 2006 Jan 10; 11(4):447-56. PubMed ID: 17309176
    [Abstract] [Full Text] [Related]

  • 17. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
    Rusch VW, Griffin BR, Livingston RB.
    J Thorac Cardiovasc Surg; 1989 Oct 10; 98(4):535-9. PubMed ID: 2552227
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM, Flentje M, Schmidt M, Pöllinger B, Gosse H, Willner J, Ulm K, Bronchial Carcinoma Therapy Group.
    J Clin Oncol; 2006 Sep 20; 24(27):4397-404. PubMed ID: 16983107
    [Abstract] [Full Text] [Related]

  • 19. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Sep 20; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 20. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion.
    Muraoka M, Oka T, Akamine S, Tagawa T, Morinaga M, Inoue M, Yamayoshi T, Hashizume S, Matsumoto K, Hayashi T, Nagayasu T.
    J Surg Oncol; 2006 Mar 15; 93(4):323-9. PubMed ID: 16496367
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.